Cargando…
High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer
BACKGROUND: The mainstay of treatment in rectal cancer is neoadjuvant radio chemotherapy prior to surgery, in an attempt to downstage the tumour, allowing for more complete removal during surgery. In 40 % of cases however, this neoadjuvant radio chemotherapy fails to achieve tumour regression, partl...
Autores principales: | Flanagan, L., Kehoe, J., Fay, J., Bacon, O., Lindner, A.U., Kay, E.W., Deasy, J., McNamara, D.A., Prehn, J.H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480907/ https://www.ncbi.nlm.nih.gov/pubmed/26071313 http://dx.doi.org/10.1186/s13014-015-0437-1 |
Ejemplares similares
-
XIAP impairs Smac release from the mitochondria during apoptosis
por: Flanagan, L, et al.
Publicado: (2010) -
Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach
por: Flanagan, L, et al.
Publicado: (2016) -
The BAX/BAK-like protein BOK is a prognostic marker in colorectal cancer
por: Carberry, Steven, et al.
Publicado: (2018) -
Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016) -
Erratum to: Calnexin, an ER stress-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancer
por: Ryan, Deborah, et al.
Publicado: (2016)